Your browser doesn't support javascript.
loading
Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R.
Lakhotia, Rahul; Dunleavy, Kieron; Abramson, Jeremy S; Link, Brian K; Powell, Bayard L; Melani, Christopher; Lucas, Andrea N; Steinberg, Seth M; Friedberg, Jonathan W; Kahl, Brad S; Little, Richard F; Bartlett, Nancy L; Noy, Ariela; Wilson, Wyndham H; Roschewski, Mark.
Affiliation
  • Lakhotia R; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Dunleavy K; Department of Hematology-Oncology, Georgetown University, Washington, DC.
  • Abramson JS; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Link BK; Department of Medicine, University of Iowa, Iowa City, IA.
  • Powell BL; Department of Internal Medicine-Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC.
  • Melani C; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Lucas AN; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Steinberg SM; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Friedberg JW; Wilmot Cancer Institute, University of Rochester, Rochester, NY.
  • Kahl BS; Lymphoma Program, Washington University School of Medicine Siteman Cancer Center, St. Louis, MO.
  • Little RF; HIV/AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD.
  • Bartlett NL; Lymphoma Program, Washington University School of Medicine Siteman Cancer Center, St. Louis, MO.
  • Noy A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Wilson WH; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Roschewski M; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Blood Adv ; 7(18): 5320-5324, 2023 09 26.
Article in En | MEDLINE | ID: mdl-37389844

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Burkitt Lymphoma Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Burkitt Lymphoma Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Country of publication: